DS9 Document EFTA00672297

From: To: [email protected]> Subject: Re: Hi Jeffrey Date: Mon, 06 Feb 2012 21:15:39 +0000 Hi Jeffrey, When is a good time to talk about placebo? When are you next in Cambridge? ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone: Email: Web: www.programinplacebostudies.org On Jan 13, 2012, at 3:15 PM, Jeffrey Epstein wrote: Im in africa until the 27th On Fri, Jan 13, 2012 at 9:05 PM, < > wrote: Hi Jeff, I'm around Monday, Martin Luther King day until 3pm. Is that a good day for a phone conversation? Alternatively, as the phone hasn't been too successful, should we meet in person? When are you in Cambridge next? ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston, MA 02215 Phone: EFTA00672297 Email: Web: www.programinplacebostudies.org On Dec 25, 2011, at 1:31 PM, Jeffrey Epstein wrote: lets alk on tues On Sun, Dec 25, 2011 at 2:04 PM, < > wrote: Is there a good time to check-in with you to get your feedback on the budget we sent you two weeks ago and on what issues would interest you in developing a partnership with our efforts in placebo studies? We're trying to think bot scientifically and strategically. Our team has all the intellectual and infrastructure resources of Harvard University and any input would be appreciated. Best, ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston MA 02215 Phone Email: Web: www.programinplacebostudies.org On Dec 5, 2011, at 2:41 PM, Jeffrey Epstein wrote: now? On Mon, Dec 5, 2011 at 1:26 PM, > wrote: EFTA00672298 I tried calling you on November 28. No answer. Our work is getting enormous media attention. (Attached is an article in this week's New Yorker. I wished it had focused more on our science and less on me. We expect coverage by "60 Minutes" in January.) This is a critical time to develop our scientific and institutional roots at Harvard. We're looking for partners to help move our research along. Would there be another time you could talk by telephone? Best ted Ted J. Kaptchuk Associate Professor of Medicine Harvard Medical School Director, Program in Placebo Studies & Therapeutic Encounter Beth Israel Deaconess Medical Center Boston. MA 02215 Phone: Email: Web: www.programinplacebostudies.org *********************************************************** The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00672299 The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00672300